Quantitative bioanalytical methods validation and implementation: best practices for chromatographic and ligand...

Area of Science:

• Pharmacokinetics and Drug Metabolism
• Analytical Chemistry
• Regulatory Science

Background:

• The Third AAPS/FDA Bioanalytical Workshop convened to address critical aspects of quantitative bioanalytical methods validation and implementation.
• The workshop focused on best practices for both chromatographic and ligand binding assays, crucial for drug development and regulatory submissions.

Framework:

• The workshop employed a format of expert presentations followed by interactive discussion sessions to foster debate and achieve consensus.
• A key objective was to clarify the bioanalytical validation requirements of regulatory agencies, aligning expectations for submissions.
• Daily proceedings were summarized to capture evolving insights and identify areas requiring further clarification or consensus.

Implementation:

• The workshop distilled proceedings into a consensus summary, presented and debated on the final day.
• It specifically addressed the practical implementation of validated bioanalytical methods in regulatory contexts.
• The summary includes both achieved consensus points and areas where further discussion on validation topics is needed.

Implications:

• This communication provides a valuable summary of reached consensus on bioanalytical method validation and implementation.
• It identifies specific validation topics where consensus was not achieved, guiding future research and regulatory dialogue.
• The findings are essential for pharmaceutical scientists, regulatory bodies, and anyone involved in drug development and bioanalysis.